Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AeBeZe Labs is a digital health company specializing in "Digital Nutrition," a framework for using digital content to influence neurochemistry and improve mental well-being. The company develops evidence-based mobile applications, such as Moodrise and Daybreak, designed to alleviate symptoms of anxiety, depression, and stress by delivering curated visual and auditory stimuli. Their platform maps digital assets to specific neurotransmitters like dopamine, oxytocin, serotonin, and endorphins to help users manage their emotional states. By bridging the gap between technology and pharmacology, AeBeZe Labs aims to provide non-invasive, accessible tools for mental health maintenance. The company's products are utilized by both individual consumers and enterprise partners looking to support employee wellness.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AeBeZe Labs.